Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT02019004
EARLY_PHASE1

A Pilot Study Testing Onabotulinum Toxin A Versus Incobotulinum Toxin A Injections for Facial Wrinkles

Sponsor: Northwestern University

View on ClinicalTrials.gov

Summary

The purpose of this study is to compare the effectiveness of Botox® (Onabotulinum Toxin A) versus Xeomin® (incobotulinum toxin A) for the treatment of forehead and glabellar (vertical lines between the eyebrows) wrinkles.

Official title: Treatment of Forehead/Glabellar Rhytide Complex With Onabotulinum Toxin A Versus Incobotulinum Toxin A Injection: A Split-face, Double-blinded, Randomized Control Trial

Key Details

Gender

All

Age Range

20 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

20

Start Date

2013-11

Completion Date

2025-12

Last Updated

2025-01-31

Healthy Volunteers

Yes

Conditions

Interventions

DRUG

Onabotulinum Toxin A

DRUG

Incobotulinum Toxin A

Locations (1)

Northwestern University Department of Dermatology

Chicago, Illinois, United States